Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

NCT06249854

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hallym University Medical Center Anyang-si, Gyeonggi-do, South Korea
  • Pusan National University Yangsan Hospital Yangsan, Gyeongsangnam-do, South Korea
  • Kyung Hee University Hospital Seoul, South Korea
  • Hanyang University Seoul Hospital Seoul, South Korea
View Trial Details
Completed

A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer

NCT06532032

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • UCI Health Irvine Hospital Irvine, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • University of California Irvine Medical Center Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oncology Hematology Associates Springfield, Missouri, United States
View all 15 locations
View Trial Details
Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States
  • [Site 11] University of California, San Diego Medical Center La Jolla, California, United States
  • [Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • [Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details
Completed

Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)

NCT04563871

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ChungBuk National University Hospital Cheonju, South Korea
  • National Cancer Center Goyang, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions